NLS Pharma Pins Hopes On Ex-Obesity Drug For ADHD
Emerging Company Profile: NLS Pharma wants to develop novel treatments for ADHD, sleep disorders and cognitive impairments. Its big hope is mazindol CR, for which it has just announced promising Phase II data. The firm explains what is next.
Register for our free email digests: